The reduction of DAT density occurs even before the onset of PD symptoms, since thereis a 40 to 60% reduction in dopaminergic activity (uptake of DAT tracers) when thefirst symptoms appear and, with the evolution of the disease, the levels of uptakedecrease by up to 90%9-11. The gene discussed is SLC6A3; the disease is Parkinson disease.